This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: Albert-Ludwigs-Universitaet Freiburg, Helmholtz-Zentrum Fur Umweltforschung Gmbh-Ufz, Other. Active years: 2001-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2001-2018
Title: Beate Strehlitz: Innovator in Aptamer Research
Introduction
Beate Strehlitz is a prominent inventor based in Leipzig, Germany. She has made significant contributions to the field of aptamer research, holding a total of 3 patents. Her work focuses on innovative methods for identifying and utilizing aptamers, which are short, single-stranded RNA or DNA molecules that can bind to specific targets.
Latest Patents
One of her latest patents is a method for identifying aptamers. This invention involves several steps, including bringing a mixture of oligonucleotides into contact with an aptamer target structure and binding some of the oligonucleotides to the target structure. The process continues with the separation of bound oligonucleotides from unbound ones, followed by amplification of the individual oligonucleotides. Each amplicon is then marked for unique identification, sequenced, and analyzed for binding properties.
Another notable patent involves aptamers that are specific for immunoglobulin-binding cell wall proteins. This invention relates to an aptamer that binds to protein A, G, or L, and includes methods for detection and enrichment of these proteins. The patent also covers a kit, biosensor, lateral flow assay device, and measuring instrument that utilize the aptamer for various applications.
Career Highlights
Throughout her career, Beate Strehlitz has worked with esteemed institutions, including Albert-Ludwigs-Universität Freiburg. Her research has significantly advanced the understanding and application of aptamers in various fields, including diagnostics and therapeutics.
Collaborations
Beate has collaborated with notable colleagues such as Bernd Grundig and Ilka Renneberg. These partnerships have further enriched her research and contributed to her innovative work in the field.
Conclusion
Beate Strehlitz is a trailblazer in aptamer research, with a focus on innovative methods that enhance the identification and application of these molecules. Her contributions have the potential to impact various scientific and medical fields significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile